Partnering Playbook - Part 3

As the life sciences industry becomes more complex, global, and tech-enabled, partnering is more essential (and more nuanced) than ever. The Partnering Playbook is MoFo’s four-part series designed to decode the strategy, structure, and execution of successful licensing and collaboration transactions. The series blends legal insight with real-world business experience, drawing on MoFo’s deep bench of life sciences deal lawyers and a network of biotech executives, VCs, pharma business development leads, and academic innovators.

Each session will explore key legal and commercial considerations across the deal life cycle, with special focus on key legal terms, cross-border transaction issues, the integration of AI into deal structures and diligence, and the evolving regulatory and IP environment.

Part 4: Beyond the Deal – Managing Partnerships and Preparing for Exit

Closing a deal is only the beginning. This session will cover best practices for managing ongoing collaborations, including alliance management frameworks, dispute resolution, and step-in rights. We’ll also explore provisions that become critical in change-of-control events, M&A transactions, and IPO readiness, such as assignment restrictions and consent requirements. Attendees will learn how to manage collaborations effectively today, while positioning themselves for long-term success and value realization.

Topics include:

• Alliance management best practices
• Dispute resolution and step-in rights
• Change-of-control provisions and assignment restrictions
• Integration of partnering agreements into M&A or IPO readiness
• Common pitfalls in long-term collaborations